Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Statistics

Total Valuation

ALNY has a market cap or net worth of $32.41 billion. The enterprise value is $32.58 billion.

Market Cap	32.41B
Enterprise Value	32.58B

Important Dates

The last earnings date was Thursday, October 31, 2024, before market open.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	n/a

Share Statistics

ALNY has 128.98 million shares outstanding. The number of shares has increased by 1.97% in one year.

Current Share Class	128.98M
Shares Outstanding	128.98M
Shares Change (YoY)	+1.97%
Shares Change (QoQ)	+1.47%
Owned by Insiders (%)	0.36%
Owned by Institutions (%)	97.40%
Float	128.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.31
Forward PS	13.43
PB Ratio	n/a
P/TBV Ratio	1,008.64
P/FCF Ratio	2,031.59
P/OCF Ratio	577.02
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	15.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	2,028.23

Financial Position

The company has a current ratio of 2.75, with a Debt / Equity ratio of 84.26.

Current Ratio	2.75
Quick Ratio	2.57
Debt / Equity	84.26
Debt / EBITDA	n/a
Debt / FCF	169.72
Interest Coverage	-1.40

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-2.92%
Return on Capital (ROIC)	-4.47%
Revenue Per Employee	$997,521
Profits Per Employee	-$158,221
Employee Count	2,100
Asset Turnover	0.52
Inventory Turnover	3.57

Taxes

In the past 12 months, ALNY has paid $11.16 million in taxes.

Income Tax	11.16M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +47.61% in the last 52 weeks. The beta is 0.32, so ALNY's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+47.61%
50-Day Moving Average	271.05
200-Day Moving Average	214.53
Relative Strength Index (RSI)	44.11
Average Volume (20 Days)	903,001

Short Selling Information

The latest short interest is 3.74 million, so 2.90% of the outstanding shares have been sold short.

Short Interest	3.74M
Short Previous Month	3.70M
Short % of Shares Out	2.90%
Short % of Float	2.91%
Short Ratio (days to cover)	3.94

Income Statement

In the last 12 months, ALNY had revenue of $2.09 billion and -$332.26 million in losses. Loss per share was -$2.62.

Revenue	2.09B
Gross Profit	1.79B
Operating Income	-188.13M
Pretax Income	-61.70M
Net Income	-332.26M
EBITDA	-132.15M
EBIT	-188.13M
Loss Per Share	-$2.62

Balance Sheet

The company has $2.78 billion in cash and $2.73 billion in debt, giving a net cash position of $54.04 million or $0.42 per share.

Cash & Cash Equivalents	2.78B
Total Debt	2.73B
Net Cash	54.04M
Net Cash Per Share	$0.42
Equity (Book Value)	32.35M
Book Value Per Share	0.25
Working Capital	2.13B

Cash Flow

In the last 12 months, operating cash flow was $56.56 million and capital expenditures -$40.49 million, giving a free cash flow of $16.06 million.

Operating Cash Flow	56.56M
Capital Expenditures	-40.49M
Free Cash Flow	16.06M
FCF Per Share	$0.12

Margins

Gross margin is 85.37%, with operating and profit margins of -8.98% and -15.86%.

Gross Margin	85.37%
Operating Margin	-8.98%
Pretax Margin	-15.33%
Profit Margin	-15.86%
EBITDA Margin	-6.31%
EBIT Margin	-8.98%
FCF Margin	13.60%

Dividends & Yields

ALNY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.97%
Shareholder Yield	-1.97%
Earnings Yield	-1.02%
FCF Yield	0.05%

Analyst Forecast

The average price target for ALNY is $298.59, which is 18.81% higher than the current price. The consensus rating is "Buy".

Price Target	$298.59
Price Target Difference	18.81%
Analyst Consensus	Buy
Analyst Count	23
Revenue Growth Forecast (5Y)	22.23%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ALNY has an Altman Z-Score of 2 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2
Piotroski F-Score	4